Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/252446
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Lithium, a potential protective drug in Alzheimer’s disease |
Autor: | Engel, Tobías; Goñi-Oliver, Paloma CSIC; Gómez de Barreda, Elena CSIC; Lucas, José Javier CSIC ORCID; Hernández, Félix; Ávila, Jesús CSIC ORCID | Fecha de publicación: | 2008 | Editor: | S. Karger AG | Citación: | Neurodegenerative Diseases 5(3-4): 247-249 (2008) | Resumen: | Alzheimer’s disease is characterized by the presence of two histopathological aberrant structures, the senile plaques and the neurofibrillary tangles. The main component of these tangles is the cytoskeletal protein tau in hyperphosphorylated form. Since a main tau kinase is glycogen synthase kinase 3 (GSK-3), the use of specific GSK-3 inhibitors, like lithium, could be a potential therapy in Alzheimer’s disease. In this short article, we have done a review on tau phosphorylation in Alzheimer’s disease and other tauopathies, and on the inhibition of kinases like GSK-3, involved in tau modification. | Versión del editor: | https://doi.org/10.1159/000113715 | URI: | http://hdl.handle.net/10261/252446 | DOI: | 10.1159/000113715 | ISSN: | 1660-2854 |
Aparece en las colecciones: | (CBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 59,24 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
45
checked on 06-abr-2024
WEB OF SCIENCETM
Citations
39
checked on 27-feb-2024
Page view(s)
39
checked on 29-abr-2024
Download(s)
7
checked on 29-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.